Skip to content

Study · Systematic review · 2023

1 result

Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: A systematic review.

Heerfordt IM, Lerche CM, Philipsen PA, Wulf HC

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie14 Dec 2022Cited by 19 (Europe PMC)

PMID36525819 (opens in a new tab)DOI10.1016/j.biopha.2022.114132 (opens in a new tab)PepBankPUB-36525819
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanSystematic reviewEfficacy outcome

    In a systematic review of treatments for skin photosensitivity in EPP or XLP, controlled trials showed a moderate positive effect of the subcutaneous afamelanotide implant.

    In plain wordsIn a review of studies in people with EPP or XLP, trials showed a moderate positive effect of the afamelanotide implant on light sensitivity.

    Peptide
    Melanotan I (afamelanotide)
    Outcome
    Not applicableSkin photosensitivity in EPP or XLP
    Study

    n: not reported in source

    Outcome group
    Skin and hair · Skin and wound
    Studied dose
    Dose not stated · subcutaneous implantAs given in this study (human).

    Source sentences

    Summary
    the trials showed moderate positive effect of inorganic sunscreen application and subcutaneous implant of afamelanotide
    2 context sentences
    Summary · context
    A total of 40 studies with data on 18 treatment modalities were included.
    Summary · context
    Of the included studies, 13 were controlled trials.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.